Earnings Releases

Duke Energy CORP reported first quarter ended March 31, 2024 results: EPS $1.44. Guidance reaffirmed.

“First-quarter 2024 reported and adjusted EPS of $1.44”

Penumbra Inc reported the first fiscal quarter ended March 31, 2024 results: revenue $278.7 million. Guidance reaffirmed.

“Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024. • Revenue of $278.7 million in the first quarter of 2024, an increase of 15.4% or 15.2% in constant currency 1 , compared to the first quarter of 2023. • U.S. thrombectomy revenue of $150.3 million in the”

Cooper-Standard Holdings Inc. reported first quarter ended March 31, 2024 results: revenue $676.4, net income $(31.7) million, EPS $(1.81) per diluted share. Guidance raised.

“guidance, assuming industry production volumes hold.” Consolidated Results Three Months Ended March 31, 2024 2023 (dollar amounts in millions except per share amounts) Sales $ 676.4 $ 682.5 Net loss $ (31.7) $ (130.4) Adjusted net loss $ (30.6) $ (46.2) Loss per diluted share $ (1.81) $ (7.57) Adjusted loss per diluted share $ (1.75) $ (2.68) Adjusted EBITDA”

Builders FirstSource, Inc. reported the three months ended March 31, 2024 results: revenue $3.9 billion, net income $258.8 million, or $2.10 per diluted share, EPS $2.10 per diluted share. Guidance reaffirmed.

“today reported its results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights All Year-Over-Year Comparisons Unless Otherwise Noted: • Net sales were $3.9 billion, a 0.2% increase, with core organic sales essentially flat, in line with expectations, and growth from acquisitions partially offset by commodity deflation. • Gross profit margin”

Sonos Inc reported second fiscal quarter ended March 30, 2024 results: revenue $252.7 million, net income ($69.7) million, EPS ($0.56). Guidance reaffirmed.

“behind us, we are well positioned to deliver on our Fiscal 2024 guidance,” said Sonos CFO Saori Casey. Second Quarter Fiscal 2024 Financial Highlights (unaudited) ● Revenue of $252.7 million ● Gross margin of 44.3% ● GAAP net loss of ($69.7) million, GAAP diluted loss per share (EPS) of ($0.56) ● Non-GAAP net loss 1 of ($42.1) million, Non-GAAP diluted EPS 1 of”

ARC DOCUMENT SOLUTIONS, INC. reported the first quarter ended March 31, 2024 results: revenue $70.8, net income $2.5, EPS $0.06.

“results for the first quarter ended March 31, 2024. Financial Highlights: Three Months Ended March 31, (All dollar amounts in millions, except EPS) 2024 2023 Net sales $ 70.8 $ 68.9 Gross margin 32.2 % 33.3 % Net income attributable to ARC $ 2.5 $ 1.9 Adjusted net income attributable to ARC $ 2.6 $ 2.2 Earnings per share - diluted $ 0.06 $ 0.04”

Consolidated Communications Holdings, Inc. reported first quarter 2024 results: revenue $274.7 million, net income ($47.2 million), EPS ($0.41).

“CNSL) (the “Company” or “Consolidated”), a top 10 fiber provider in the U.S., today reported results for first quarter 2024. First Quarter 2024 Results ​ ● Revenue totaled $274.7 million ● Overall consumer revenue was $114.8 million ● Consumer fiber broadband revenue was $41.6 million ● Total consumer broadband net adds were 6,338 ● Consumer broadband revenue was”

Inogen Inc reported quarter ended March 31, 2024 results: revenue $78.0 million, net income $14.6 million.

“while strengthening our market leading position. I am excited for the future of Inogen.” First Quarter 2024 Financial Results First quarter total revenue increased 8.1% to $78.0 million from $72.2 million in the first quarter of 2023, primarily driven by higher international and domestic business-to business sales, partially offset by lower direct-to-consumer”

MAXCYTE, INC. reported the quarter ended March 31, 2024 results: revenue $11.3 million, net income $9.5 million. Guidance raised.

“applications, today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance. ​ First Quarter Highlights ​ · Total revenue of $11.3 million in the first quarter of 2024, an increase of 32% over the first quarter of 2023. · Core business revenue of $8.2 million in the first quarter of 2024, an increase of 5% over the”

LEGALZOOM.COM, INC. reported the three months ended March 31, 2024 results: revenue $174.2 million, net income $4.7 million, EPS $0.02.

“LegalZoom Reports First Quarter 2024 Financial Results • Revenue of $174.2 million for the quarter, an increase of 5% year-over-year”

ClearPoint Neuro, Inc. reported the first quarter ended March 31, 2024 results: revenue $7.6 million. Guidance reaffirmed.

“precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2024. First Quarter Highlights • Reported quarterly revenue of $7.6 million, a 41% year-over-year increase; • Increased biologics and drug delivery revenue to $4.3 million, a 61% year-over-year increase; • Partner PTC Therapeutics submitted first-ever”

MidCap Financial Investment Corp reported the quarter ended March 31, 2024 results: net income $28.5, EPS $0.44.

“On May 7, 2024, MidCap Financial Investment Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”

MARKETAXESS HOLDINGS INC reported first quarter ended March 31, 2024 results: revenue $210.3 million, net income $72.6 million, EPS $1.92.

“for fixed-income securities, today announced financial results for the first quarter ended March 31, 2024. 1Q24 select financial and operational highlights* • Total revenues of $210.3 million , up 3.5% , includes Pragma revenues of $7.5 million and an increase of approximately $0.8 million from the impact of foreign currency fluctuations. — Strong growth in U.S.”

ASSURED GUARANTY LTD reported first quarter 2024 results: net income $109 million, EPS $1.89 per share.

“Net income attributable to Assured Guaranty Ltd. was $109 million, or $1.89 per share (1) , for first quarter 2024.”

TransDigm Group INC reported second quarter ended March 30, 2024 results: revenue $1,919 million, net income $404 million, EPS $6.97. Guidance raised.

“and supplier of highly engineered aircraft components, today reported results for the second quarter ended March 30, 2024. Second quarter highlights include: • Net sales of $1,919 million, up 21% from $1,592 million in the prior year's quarter; • Net income of $404 million, up 33% from the prior year's quarter; • Earnings per share of $6.97, up 31% from the prior”

GLOBUS MEDICAL INC reported three-month period ended March 31, 2024 results: revenue $606.7 million, net income $7.1 million net loss, EPS ($0.05).

“Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 3 1 , 202 4 .  · Worldwide net sales were $ 606.7 million , an increase of 119 . 3 % , or 119.8% on a constant currency basis · GAAP net loss for the quarter was $ 7. 1 million · GAAP d iluted e arnings p er share (“ EPS ”) was ( $0. 0”

ASHFORD HOSPITALITY TRUST INC reported financial results for first quarter ended March 31, 2024.

“On May 7, 2024, Ashford Hospitality Trust, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.”

COMPASS MINERALS INTERNATIONAL INC reported fiscal 2024 second quarter results: revenue $ 364.0, net income $(48.0), EPS $(1.16).

“across all operating sites. QUARTERLY FINANCIAL RESULTS Three Months Ended March 31, Six Months Ended March 31, (in millions, except per share data) 2024 2023 2024 2023 Revenue $ 364.0 $ 411.1 $ 705.7 $ 763.5 Operating (loss) earnings (45.8) 47.9 (101.1) 75.8 Adjusted operating earnings * 65.4 50.8 87.4 79.0 Adjusted EBITDA * 87.3 77.4 146.7 139.2 Net loss”

Neuronetics, Inc. reported first quarter of 2024; three months ended March 31, 2024 results: revenue $17.4 million, net income $(7.9) million, or $(0.27) per share, EPS $(0.27) per share.

“therapies in the world, today announced its financial and operating results for the first quarter of 2024. First Quarter 2024 Highlights ● First quarter 2024 revenue of $17.4 million, a 12% increase as compared to the first quarter 2023 ● U.S. treatment session revenue increased by 22% versus the first quarter of 2023 ● U.S. NeuroStar Advanced Therapy system”

MARCHEX INC reported first quarter ended March 31, 2024 results: revenue $11.6 million, net income $1.5 million, EPS $0.03 per diluted share.

“excellence and revenue acceleration, today announced its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights • GAAP revenue was $11.6 million for the first quarter of 2024, compared to $12.2 million for the first quarter of 2023. • Net loss was $1.5 million for the first quarter of 2024 or $0.03 per diluted share,”

BIO-RAD LABORATORIES, INC. reported the first quarter ended March 31, 2024 results: revenue $610.8 million, net income $383.9 million, EPS $13.45 per share, on a diluted basis.

“Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023. On a currency-neutral basis, quarterly sales decreased 9.6 percent compared to the same period in 2023. Life Science segment net sales for the first quarter were $241.7 million, a decrease of 25.3 percent compared to the same period in 2023. On a currency-neutral basis, Life Science segment sales decreased by 25.2 percent compared to the same quarter in 2023. The currency-neutral year-over-year sales decrease was broad-based and was primarily driven by ongoing weakness in the biotech and biopharma end-markets and the economic environment in China. Clinical Diagnostics segment net sales for the first quarter were $368.6 million, an increase”

SOMNIGROUP INTERNATIONAL INC. reported first quarter ended March 31, 2024 results: revenue $1.2 Billion, net income $76.3 million, EPS $0.43. Guidance reaffirmed.

“RESULTS) --- EX-99.1 2 tpxreports1q2024results.htm TPX REPORTS FIRST QUARTER 2024 RESULTS Document TEMPUR SEALY REPORTS FIRST QUARTER RESULTS - First Quarter 2024 Net Sales of $1.2 Billion, Consistent with Prior Year - Strong Consolidated Gross Margins up 1.7% to 43.1% - EPS of $0.43 and Adjusted EPS (1) of $0.50 - Record First Quarter Cash Flow from Operations of”

AMERICAN PUBLIC EDUCATION INC updated its full year 2024 guidance (raised).

“· Increasing guidance for full year Revenue and Adjusted EBITDA”

AMERICAN PUBLIC EDUCATION INC reported three months ended March 31, 2024 results: revenue $154.4 million, net income ($1.0) million, EPS ($0.06).

“· Consolidated revenue for Q1 2024 increased 3.2% year-over-year to $154.4 million. · Net loss available to common stockholders in Q1 2024 was ($1.0) million, compared to a net loss available to common stockholders of ($7.2) million in the prior year period. · Net loss per diluted common share in Q1 2024 was ($0.06), compared to a net loss per diluted common share of ($0.38) in the same period of 2023.”

ONCOR ELECTRIC DELIVERY CO LLC reported three months ended March 31, 2024 results: net income net income of $225 million compared to reported three months ended March 31, 2023 net income of $103 million.

“ONCOR REPORTS FIRST QUARTER 2024 RESULTS DALLAS (May 7, 2024) — Oncor Electric Delivery Company LLC (“Oncor”) today reported three months ended March 31, 2024 net income of $225 million compared to reported three months ended March 31, 2023 net income of $103 million.”

WYNN RESORTS LTD reported first quarter ended March 31, 2024 results: revenue $1.86 billion, net income $144.2 million, EPS $1.30.

“Operating revenues were $1.86 billion for the first quarter of 2024”

HYSTER-YALE, INC. reported the three month period ended March 31, 2024 results: revenue $1,056.5, net income $51.5, EPS $2.93.

“are to the three months ended March 31, 2023, unless otherwise noted. Three Months Ended ($ in millions except per share amounts) 3/31/24 3/31/23 Change Fav (Unfav) Revenues $1,056.5 $999.3 $57.2 Operating Profit $83.8 $42.6 $41.2 Net Income $51.5 $26.6 $24.9 Diluted Earnings per Share $2.93 $1.55 $1.38 Lift Truck Business Results Revenues and shipments by”

NATURAL RESOURCE PARTNERS LP reported first quarter of 2024 results: net income Net income $ 56,213.

“On May 7, 2024, Natural Resource Partners L.P. announced via press release its earnings and operating results for the first quarter of 2024.”

IROBOT CORP reported first quarter ended March 30, 2024 results: revenue $150.0 million, EPS $0.30. Guidance reaffirmed.

“(NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the first quarter ended March 30, 2024. First-Quarter Financial Highlights • Revenue of $150.0 million, compared with $160.3 million in Q1 of 2023. • GAAP net income per share was $0.30 compared with GAAP net loss per share of ($2.95) in Q1 of 2023. • Non-GAAP net loss per share”

HALOZYME THERAPEUTICS, INC. reported the first quarter ended March 31, 2024 results: revenue $195.9 million, net income $76.8 million. Guidance reaffirmed.

“any general incorporation language in such filing. --- EX-99.1 (EX-99.1) --- HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS Revenue Increased 21% YOY to $196 million; Net Income of $77 million; Adjusted EBITDA of $116 million; GAAP Diluted EPS of $0.60 and Non-GAAP Diluted EPS of $0.79 1 Royalty Revenue Increased 21% YOY to $121 million”

COMSCORE, INC. reported the quarter ended March 31, 2024 results: revenue $86.8 million, net income Net loss of $1.1 million, EPS $(1.08). Guidance reaffirmed.

“and evaluating media across platforms, today reported financial results for the quarter ended March 31, 2024. Q1 2024 Financial Highlights • Revenue for the first quarter was $86.8 million compared to $91.6 million in Q1 2023 • Net loss of $1.1 million compared to $8.7 million in Q1 2023 • Adjusted EBITDA of $8.1 million compared to $5.2 million in Q1 2023 •”

MADRIGAL PHARMACEUTICALS, INC. reported financial results for first-quarter 2024.

“On May 7, 2024, Madrigal Pharmaceuticals, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the fiscal quarter ended March 31, 2024.”

POWER SOLUTIONS INTERNATIONAL, INC. reported first quarter of 2024 results: revenue $95.2 million, net income $7.1 million, EPS $0.31.

“Today, Power Solutions International, Inc., reported results for the three months ended March 31, 2024 , with first quarter of 2024 net income of $7.1 million and diluted earnings per share of $0.31, compared to net income of $3.7 million and diluted earnings per share of $0.16 for the first quarter of 2023. Sales for the first quarter of 2024 were $95.2 million, a decrease of $21.2 million, or 18%, compared to the first quarter of 2023”

SYNCHRONOSS TECHNOLOGIES INC reported its first quarter ended March 31, 2024 results: revenue $43.0 million, net income $2.3 million, EPS $0.23. Guidance reaffirmed.

“except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Synchronoss Technologies Reports First Quarter 2024 Results Q1 Revenue Grew to $43.0 Million, Surpassing 91% Recurring Revenue GAAP Gross Margin Expands to 67%; Adjusted Gross Margin Rises to 76% Streamlined Operations Improve Profitability with Net Income Increasing by”

Cryoport, Inc. reported the first quarter ended March 31, 2024 results: revenue $54.6 million, net income $0.43 per share, EPS $0.43 per share. Guidance reaffirmed.

“filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 tm2413756d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cryoport Reports First Quarter 2024 Financial Results § Q1 2024 revenue of $54.6 million § 9% year-over-year increase in Commercial Cell & Gene Therapy revenue § 9% year-over-year increase in BioStorage/BioServices revenue § A total of 675 global clinical trials”

HARVARD BIOSCIENCE INC reported first quarter ended March 31, 2024 results: revenue $24.5, net income $(4.7), EPS $(0.11) per diluted share.

“continue to expect solid growth in the second half.” Financial Results Summary Three Months Ended March 31, (unaudited, $ in millions except per share data) 2024 2023 Revenues $ 24.5 $ 30.0 Gross margin 60.3 % 61.2 % Operating (loss) income (GAAP) $ (2.3 ) $ 1.7 Adjusted operating income $ 1.2 $ 4.4 Net (loss) income (GAAP) $ (4.7 ) $ 0.6 Diluted (loss)”

AVIENT CORP reported first quarter of 2024 results: revenue sales of $829.0 million, EPS GAAP EPS from continuing operations of $0.54. Guidance raised.

“AVNT), a leading provider of specialized and sustainable materials solutions, today announced its first quarter results for 2024. The company reported first quarter sales of $829.0 million compared to $845.7 million in the prior year quarter. First quarter GAAP earnings per share (EPS) from continuing operations was $0.54 compared to $0.23 in the prior year”

ON24 INC. reported the first quarter ended March 31, 2024 results: revenue $37.7 million, net income $(0.26) per diluted share.

“shall be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- ON24 Announces First Quarter 2024 Financial Results • Achieved Total Revenue of $37.7 million and exceeded profitability targets for 4th consecutive quarter • Continued signs of stabilization in customer base driven by positive trends in gross retention • Strong”

CURIS INC reported first quarter ended March 31, 2024 results: revenue $2.1 million, net income net loss of $11.9 million or $2.05 per share on both a basic and diluted basis.

“For the first quarter of 2024, Curis reported a net loss of $11.9 million or $2.05 per share on both a basic and diluted basis as compared to $11.6 million or $2.39 per share on both a basic and diluted basis, for the same period in 2023. Revenues for the first quarter of 2024 were $2.1 million as compared to $2.3 million for the same period in 2023.”

QUALYS, INC. reported the first quarter ended March 31, 2024 results: revenue $145.8 million, net income $39.7 million, EPS $1.05 per diluted share. Guidance raised.

“For the quarter, the Company reported revenues of $145.8 million, net income under United States Generally Accepted Accounting Principles (“U.S. GAAP”) of $39.7 million, non-GAAP net income of $54.7 million, Adjusted EBITDA of $69.0 million, GAAP net income per diluted share of $1.05, and non-GAAP net income per diluted share of $1.45.”

AGENUS INC reported financial results for the quarter ended March 31, 2024.

“On May 7, 2024, Agenus Inc. announced its financial results for the quarter ended March 31, 2024. In connection with the announcement, the Company issued a press release, which is being furnished as Exhibit 99.1 to this current report on Form 8-K.”

YORK WATER CO reported the first quarter of 2024 results: revenue $17,628,000, net income $4,327,000, EPS $0.30.

“The York Water Company's (NASDAQ:YORW) President, JT Hand, announced the Company's financial results for the first quarter of 2024. President Hand reported that first quarter operating revenues of $17,628,000 increased $2,227,000 and net income of $4,327,000 increased $674,000 compared to the first quarter of 2023. Basic and Diluted Earnings per share of $0.30 for the three-month period increased $0.04 compared to the same period last year.”

KRATOS DEFENSE & SECURITY SOLUTIONS, INC. reported first quarter 2024 results: revenue $277.2 million, net income Net Income attributable to Kratos of $1.3 million, EPS $0.01.

“Kratos Reports First Quarter 2024 Financial Results First Quarter 2024 Revenues of $277.2 Million Increased 19.6 Percent over First Quarter 2023 Revenues of $231.8 Million, including 19.5 Percent Organic Growth”

CUMBERLAND PHARMACEUTICALS INC reported the three months ended March 31, 2024 results: revenue $8.5 million.

“Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with $82 million in total assets, $54 million in total liabilities and $27 million of shareholders’ equity. “It”

Astrana Health, Inc. updated its first quarter ended March 31, 2024 guidance (reaffirmed).

“On May 7, 2024, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference.”

NOVANTA INC reported first quarter 2024 results: revenue $231 million, net income $15 million, EPS $0.41.

“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE May 7, 2024 Novanta Announces Financial Results for the First Quarter 2024 • First Quarter 2024 GAAP Revenue of $231 million • First Quarter 2024 GAAP Net Income of $15 million • First Quarter 2024 GAAP Diluted Earnings Per Share of $0.41 • First Quarter 2024 Adjusted Earnings Per Share of $0.74 •”

Crexendo, Inc. reported the first quarter ended March 31, 2024 results: revenue $14.3 million, net income $434,000, or $0.02 per basic common share and $0.01 per diluted common share, EPS $0.02 per basic common share and $0.01 per diluted common share.

“size business, today announced financial results for the first quarter ended March 31, 2024. First Quarter Financial highlights: · Total revenue increased 14% year-over-year to $14.3 million · GAAP net income of $434,000, or $0.02 per basic common share and $0.01 per diluted common share · Non-GAAP net income of $1.9 million, or $0.07 per basic common share and $0.06”

CF BANKSHARES INC. reported the first quarter ended March 31, 2024 results: net income $3.1 million ( $0.47 per diluted common share ), EPS $0.47 per diluted common share.

“CF Bankshares Inc. (NASDAQ: CFBK) (the “Company”), the parent of CFBank, National Association (“CFBank”), today announced financial results for the first quarter ended March 31, 2024.”

BERKSHIRE HATHAWAY INC reported first quarter ended March 31, 2024 results: net income $ 12,702, EPS $ 8,825.

“On May 4, 2024, Berkshire Hathaway Inc. issued a press release announcing the Company’s earnings for the first quarter ended March 31, 2024.”

WEYCO GROUP INC reported the quarter ended March 31, 2024 results: revenue $71.6 million, net income $6.7 million, EPS $0.69 per diluted share.

“(NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended March 31, 2024. ​ First Quarter 2024 Consolidated net sales were $71.6 million, down 17% compared to record first-quarter sales of $86.3 million in 2023. Consolidated gross earnings increased to 44.7% of net sales compared to 43.1% of net sales in last”